Minerva Neurosciences Inc. appointed Rick Russell as president of the company.
The appointment follows CEO Remy Luthringer's resignation as the president of the company.
Russell was most recently the president and CEO of Ares Allergy Holdings Inc., which is now the global biopharmaceutical company Stallergenes Greer PLC.
Separately, Minerva Neurosciences appointed William Doyle and Hans Hasler as directors of the company.
Doyle is the executive chairman of NovoCure Ltd., a commercial stage oncology company.
Hasler is the founder and CEO of Vicarius Pharma AG.
